Ad hoc reports in accordance with Sec. 15 of the German Securities Trading Act - Dräger increases net sales in 2010 by around 14 percent

Friday, 14. January 2011 17:02
Drägerwerk AG & Co. KGaA /
Ad hoc reports in accordance with Sec. 15 of the German Securities Trading Act -
Dräger increases net sales in 2010 by around 14 percent
Processed and transmitted by Thomson Reuters.
The issuer is solely responsible for the content of this announcement.

EBIT margin at the upper limit of the forecast

According to preliminary estimates, Drägerwerk AG & Co. KGaA achieved net sales
growth of around 14 percent and record net sales of EUR 2.2 billion in 2010
compared to EUR 1.9 billion in 2009. In October 2010, the company still
anticipated net sales growth around 10 percent. The EBIT margin reached 8 to 9
percent, the upper limit of the 2010 forecast. Order intake rose by around 9
percent year on year to EUR 2.2 billion.

The medical division recorded order intake of around 8 percent and generated net
sales of EUR 1.5 billion - an increase of approximately 17 percent compared to
the previous year. The EBIT margin was around 12 percent according to
preliminary estimates. In the safety division, order intake went up by about 10
percent and net sales reached EUR 0.7 billion, corresponding to a rise of around
9 percent compared to 2009. The EBIT margin came to around 9 percent according
to preliminary estimates.

The reasons for the positive net sales and earnings development were the
unexpectedly high order intake in the fourth quarter of 2010, continuous
positive developments in the Americas and Asia/Pacific and favorable currency
effects. The turnaround program also had an extremely positive effect.

In 2011, Dräger will invest even larger sums into research and development,
implement projects even more quickly and improve its marketing and sales
organization in particular. For this reason, Dräger expects slightly higher
group net sales in 2011 and an EBIT margin between 7.5 percent and 8.5 percent.
The estimated development of net sales and margins in fiscal year 2011 is based
on the assumption that the markets relevant to Dräger will continue their steady
development and that exchange rates will remain at the current level. In the
medium term, the company plans to grow faster than the market and achieve a
minimum EBIT margin of 10 percent in the long term.

Drägerwerk AG & Co. KGaA
Moislinger Allee 53-55
23558 Lübeck, Deutschland

Investor Relations:
Vanina Hoffmann
Phone:+49 451 882-2685

Corporate Communications:
Burkard Dillig
Phone +49 451 882-2185

This press release contains forward-looking statements regarding the future
development of the Dräger Group. These forward-looking statements are based on
the current expectations, presumptions, and forecasts of the Executive Board as
well as the information available to it to date and have been prepared to the
best of its knowledge and belief. No guarantee or liability for the occurrence
of the future developments and results specified can be assumed in respect of
such forward-looking statements. Rather, the future developments and results are
dependent on a number of factors. They entail risks and uncertainties beyond the
Company's control and are based on assumptions which could prove to be
incorrect. Notwithstanding any legal requirements to adjust forecasts, we assume
no obligation to update the forward-looking statements contained in this report.
You will find all other financial dates on our website under
Investor Center/Financial Calendar.

--- End of Message ---

Drägerwerk AG & Co. KGaA
Moislinger Allee 53-55 Lübeck Germany

Listed: Freiverkehr in Börse Stuttgart,
Prime Standard in Frankfurter Wertpapierbörse,
Regulierter Markt in Frankfurter Wertpapierbörse,
Regulierter Markt in Bayerische Börse München,
Regulierter Markt in Börse Berlin,
Regulierter Markt in Hanseatische Wertpapierbörse zu Hamburg,
Regulierter Markt in Börse Düsseldorf,
Regulierter Markt in Niedersächsische Börse zu Hannover;

Press release (PDF):

This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.

Source: Drägerwerk AG & Co. KGaA via Thomson Reuters ONE

Related Links: Drägerwerk AG & Co. KGaA
Copyright GlobeNewswire, Inc. 2016. All rights reserved.
You can register yourself on the website to receive press releases directly via e-mail to your own e-mail account.